共 50 条
- [21] Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE studyLIVER INTERNATIONAL, 2015, 35 (02) : 448 - 454Berg, ThomasAndreone, PietroPol, StanislasRoberts, StuartYounossi, ZobairDiago, MoisesLawitz, Eric J.Focaccia, RobertoFoster, Graham R.Horban, AndrzejLonjon-Domanec, IsabelleDeMasi, RalphPicchio, GastonLuo, DonghanDe Meyer, SandraZeuzem, Stefan
- [22] Genotype-specific assessment of predictive factors for sustained virologic response after standard treatment in patients chronically infected with HCVJOURNAL OF HEPATOLOGY, 2007, 46 : S226 - S226Martens, S.Weich, V.Berg, T.Sarrazin, C.Hinrichsen, H.Buggisch, P.Spengler, U.Klinker, H.Zeuzem, S.Herrmann, E.
- [23] Viral genotype and titer are independent predictors of sustained virologic response in HCV patients treated with interferons.HEPATOLOGY, 1997, 26 (04) : 1657 - 1657Krawitt, EBalart, LACassidy, WMLyche, KD
- [24] HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patientsAIDS, 2002, 16 (03) : 387 - 396Falloon, JAit-Khaled, MThomas, DABrosgart, CLEron, JJFeinberg, JFlanigan, TPHammer, SMKraus, PWMurphy, RTorres, RMasur, H
- [25] Telaprevir in Combination with Peginterferon Alfa-2a and Ribavirin Increased Sustained Virologic Response in Genotype 1 Chronic HCV and Allowed for Shorter Treatment Duration in Treatment-naive and Prior Relapser PatientsAMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S113 - S114Everson, GregoryDusheiko, GeoffreyPol, StanislasNelson, DavidMuir, AndrewAndreone, PietroKauffman, RobertAdda, NathalieWright, ChristopherBengtsson, LeifMartin, MarieSankoh, AbdulGeorge, ShelleySherman, KennethJacobson, IraZeuzem, Stefan
- [26] Meta-Analysis: Sustained Virologic Response at 12 Weeks (SVR12) With Simeprevir and Sofosbuvir (SMV plus SOF) in Liver Transplant (LT) Recipients With HCV Genotype 1 (HCV-1)GASTROENTEROLOGY, 2015, 148 (04) : S1091 - S1092Nghia NguyenYee, Brittany E.Lutchman, GlenLim, Joseph K.Nguyen, Mindie H.
- [27] High ribavirin dose and extended treatment can raise sustained virologic response in chronic hepatitis C genotype 1 patients treated with simeprevir, pegylated interferon plus ribavirinHEPATOLOGY, 2015, 62 : 804A - 804ATahata, YukiHiramatsu, NaokiOze, TsugikoUrabe, AyakoMorishita, NaokiYamada, RyokoYakushijin, TakayukiSaji, YukikoDoi, YoshinoriHagiwara, HidekiKaneko, AkiraFukui, HiroyukiInada, MasamiKatayama, KazuhiroInoue, AtsuoYoshida, YuichiTatsumi, TomohideHayashi, NorioTakehara, Tetsuo
- [28] SUSTAINED VIROLOGIC RESPONSE IN HIGH VIRAEMIC GENOTYPE-1 HCV INFECTION CORRELATES WITH PERIPHERAL HCV-SPECIFIC CYTOTOXIC RESPONSE RESTORATIONJOURNAL OF HEPATOLOGY, 2011, 54 : S121 - S121Larrubia, J. R.Benito, S.Lokhande, M.Miquel, J.Calvino, M.Sanz-de-Villalobos, E.Gonzalez-Praetorious, A.Albertos, S.Garcia-Garzon, S.Parra-Cid, T.
- [29] Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and CirrhosisCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (06) : 1029 - +Rodriguez-Torres, MaribelStoehr, AlbrechtGane, Edward J.Serfaty, LawrenceLawitz, EricZhou, AmyBourque, MichaelBhanja, SanhitaStrizki, JulieBarnard, Richard J. O.Hwang, Peggy M. T.DiNubile, Mark J.Mobashery, Niloufar
- [30] Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover studyBMC Infectious Diseases, 17Edward J. GaneEdwin DeJesusEwa JanczewskaJacob GeorgeMoises DiagoMariliza Hendrique Da SilvaHenk ReesinkIgor NikitinHolger HinrichsenStefan BourgeoisPeter FerenciUmesh ShuklaRonald KalmeijerOliver LenzBart FeveryChris CorbettMaria BeumontWolfgang Jessner
